Serina Therapeutics, Inc. (SER) has 7 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $725K. Most recent filing: July 23, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 23, 2026 filed July 22, 2026 | Simon Farrell Director | $0 | 30,500 | 0% | No | |
|
|
||||||
| July 9, 2026 filed July 7, 2026 | Brannan Stephen K. Director | +$2,030 | 1,000 | New | No | |
|
|
||||||
| June 22, 2026 filed May 22, 2026 | Venkatesan Jay Director | +$722,572 | 336,516 | — | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Brannan Stephen K. Director | $0 | 15,250 | 0% | No | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Bailey Gregory Director | $20,699,378 | 12,548,603 | — | No | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free